Shift Pharmaceuticals Holdings
UEI: L5YJHR8PKA96
• CAGE: 7TJM2
Overview
Awardee Type
Parent
Name
Shift Pharmaceuticals Holdings
Headquarters
Columbia, MO
United States
United States
Most Recent Award
April 1, 2023
Calculating
Federal grant recipient
SHIFT PHARMACEUTICALS HOLDINGS, INC
(UEI L5YJHR8PKA96, CAGE 7TJM2)
is headquartered in Columbia MO.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in December 2018 and
federally registered in
May 2019.
Federal Award Analysis
Shift Pharmaceuticals Holdings federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
SHIFT PHARMACEUTICALS HOLDINGS, INC
UEI
L5YJHR8PKA96
CAGE Code
7TJM2
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Dec. 18, 2018
Initial Registration
May 16, 2019
Last Registration
Dec. 24, 2024
Registration Activation
Dec. 24, 2024
Registration Expiration
Dec. 23, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
MO
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No